Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Chang

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Neuro-Oncology|March 29, 2018
Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group reportIlya Laufer, Simon S Lo, Eric L Chang, et al.
Frontiers in Oncology|October 8, 2024
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyondAnaliz Rodriguez, Manmeet S Ahluwalia, Chetan Bettegowda, et al.
Neuro-Oncology|April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumorsBenjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
Human Molecular Genetics|April 16, 2008
The molecular mechanism underlying Roberts syndrome involves loss of ESCO2 acetyltransferase activityMiriam Gordillo, Hugo Vega, Alison H Trainer, et al.
Neuro-Oncology|June 10, 2020
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomasJerrold L Boxerman, Chad C Quarles, Leland S Hu, et al.
Neuro-Oncology|August 8, 2015
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trialsBenjamin M Ellingson, Martin Bendszus, Jerrold Boxerman, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Acta Neuropathologica|September 10, 2018
The genetic landscape of gliomas arising after therapeutic radiationGiselle Y López, Jessica Van Ziffle, Courtney Onodera, et al.
Neuroradiology|July 19, 2023
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortiumMatthew D Lee, Sohil H Patel, Suyash Mohan, et al.
Neuro-Oncology|June 21, 2024
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directionsJessica A Wilcox, Ugonma N Chukwueke, Myung-Ju Ahn, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Neuro-Oncology|March 29, 2018
Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group reportIlya Laufer, Simon S Lo, Eric L Chang, et al.
Frontiers in Oncology|October 8, 2024
Toward standardized brain tumor tissue processing protocols in neuro-oncology: a perspective for gliomas and beyondAnaliz Rodriguez, Manmeet S Ahluwalia, Chetan Bettegowda, et al.
Neuro-Oncology|April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumorsBenjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
Human Molecular Genetics|April 16, 2008
The molecular mechanism underlying Roberts syndrome involves loss of ESCO2 acetyltransferase activityMiriam Gordillo, Hugo Vega, Alison H Trainer, et al.
Neuro-Oncology|June 10, 2020
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomasJerrold L Boxerman, Chad C Quarles, Leland S Hu, et al.
Neuro-Oncology|August 8, 2015
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trialsBenjamin M Ellingson, Martin Bendszus, Jerrold Boxerman, et al.
Nature Genetics|July 7, 2009
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibilityMargaret Wrensch, Robert B Jenkins, Jeffrey S Chang, et al.
Acta Neuropathologica|September 10, 2018
The genetic landscape of gliomas arising after therapeutic radiationGiselle Y López, Jessica Van Ziffle, Courtney Onodera, et al.
Neuroradiology|July 19, 2023
Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortiumMatthew D Lee, Sohil H Patel, Suyash Mohan, et al.
Neuro-Oncology|June 21, 2024
Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directionsJessica A Wilcox, Ugonma N Chukwueke, Myung-Ju Ahn, et al.
Pageof 12